[1] Hu Y,Shen Y,Wu X,et al. Synthesis and biological evaluation of
coumarin derivatives containing imidazole skeleton as potential antibacterial
agents.[J]. European Journal of Medicinal Chemistry,2018, 143(36):
958-962.
[2] 史翱翔,孙利花.多重耐药菌医院感染的分析与控制[J]. 中国冶金工业医学杂志,2016,33(5):505-507.
[3] Tian J,Zhang J,Yang J,et al. Conjugated polymers act synergistically
with antibiotics to combat bacterial drug resistance[J]. Acs Applied
Materials & Interfaces,2017,9(22):336-342.
[4] 陈亚男,刘菁,田丽梅,等. ICU多重耐药菌目标性监测与干预效果分析[J]. 中国感染控制杂志,2017,16(1):58-61.
[5] Hailu D,Derbie A,Mekonnen D,et al. Drug resistance patterns of bacterial
isolates from infected wounds at bahir dar regional health research
laboratory center, northwest ethiopia[J]. Ethiopian Journal of Health
Development,2017,30(3):112-117.
[6] 中华人民共和国卫生部.多重耐药菌医院感染预防与控制技术指南(试行)[J]. 中华危重病急救医学,2011,13(2):108-109.
[7] 李晋华,车昌燕.产超广谱β-内酰胺酶肺炎克雷伯菌的临床分布及耐药特征[J]. 检验医学与临床,2017,14(6):788-790.
[8] Mischnik A, Baumert P, Hamprecht A, et al. Susceptibility to cephalosporin
combinations and aztreonam/avibactam among third-generation
cephalosporin-resistant enterobacteriaceae recovered on hospital
admission[J]. International Journal of Antimicrobial Agents, 2017,
49(2):239-246.
[9] 曹茜,尤忠孝,方宏伟,等.基层医院多重耐药菌临床分布及护理措施[J]. 疾病监测与控制,2018,12(1):72-74.
[10] 袁晓宁. 多重耐药菌的形成机理及其防控措施研究进展[J]. 中国消毒学杂志,2016,33(8):792-796.
[11] 仓决吉巴,仁春梅,石荔.拉萨市某三甲医院院内感染及多重耐药菌感染特点分析[J]. 西藏医药,2018,392(2):1-3.
[12] 赵红霞,轩凯.某综合医院多重耐药菌感染类型调查[J].中国消毒学杂志, 2015,32(2):180-181.
[13] 王康椿,谭俊青,李蔼文.某院近5年多重耐药菌流行病学特点及耐药性研究[J]. 国际检验医学杂志,2016,37(16):2280-2282.
|